Hello all - we have some important news and encourage everyone to visit our website for additional information.
We announced that a recent independent review of our imaging data was positive and we are now setting a priority path to market for our MagSense imaging agent technology.
- Blinded review by expert panel of radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance Imaging (MRI).
- We are now prioritizing the development of our pipeline of tumour targeting MagSense® imaging agents for use with widely available commercial MRI systems as a faster path to patients and the market.
We will also be hosting a live webinar on 7 Feb @ 12pm AEDT to provide additional details and answer questions. We hope you join us!
Learn more: https://imagionbiosystems.com/news/priority-path-to-market-for-magsense-technology/
- Forums
- ASX - By Stock
- Ann: Company Update - Phase 1 Study Independent Review
Hello all - we have some important news and encourage everyone...
-
-
- There are more pages in this discussion • 185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
|
|||||
Last
8.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.677M |
Open | High | Low | Value | Volume |
8.2¢ | 8.2¢ | 8.2¢ | $618 | 7.542K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14698 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.6¢ | 17004 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 14698 | 0.082 |
1 | 15000 | 0.081 |
2 | 51991 | 0.080 |
1 | 13155 | 0.076 |
2 | 32500 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.086 | 17004 | 2 |
0.087 | 1250 | 1 |
0.089 | 295 | 1 |
0.090 | 1479 | 2 |
0.095 | 13008 | 1 |
Last trade - 15.09pm 04/07/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |